- Home
- ERAS vs NUS Comparison
ERAS vs NUS Comparison
Compare ERAS & NUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERAS
- NUS
- Stock Information
- Founded
- ERAS 2018
- NUS 1984
- Country
- ERAS United States
- NUS United States
- Employees
- ERAS N/A
- NUS N/A
- Industry
- ERAS Biotechnology: Pharmaceutical Preparations
- NUS Other Pharmaceuticals
- Sector
- ERAS Health Care
- NUS Health Care
- Exchange
- ERAS Nasdaq
- NUS Nasdaq
- Market Cap
- ERAS 484.4M
- NUS 440.8M
- IPO Year
- ERAS 2021
- NUS 1996
- Fundamental
- Price
- ERAS $1.41
- NUS $8.33
- Analyst Decision
- ERAS Strong Buy
- NUS Hold
- Analyst Count
- ERAS 6
- NUS 2
- Target Price
- ERAS $4.83
- NUS $6.88
- AVG Volume (30 Days)
- ERAS 852.4K
- NUS 421.6K
- Earning Date
- ERAS 08-11-2025
- NUS 08-07-2025
- Dividend Yield
- ERAS N/A
- NUS 2.93%
- EPS Growth
- ERAS N/A
- NUS N/A
- EPS
- ERAS N/A
- NUS N/A
- Revenue
- ERAS N/A
- NUS $1,679,268,000.00
- Revenue This Year
- ERAS N/A
- NUS N/A
- Revenue Next Year
- ERAS N/A
- NUS N/A
- P/E Ratio
- ERAS N/A
- NUS N/A
- Revenue Growth
- ERAS N/A
- NUS N/A
- 52 Week Low
- ERAS $1.01
- NUS $5.32
- 52 Week High
- ERAS $3.31
- NUS $10.88
- Technical
- Relative Strength Index (RSI)
- ERAS 40.59
- NUS 46.67
- Support Level
- ERAS $1.34
- NUS $8.00
- Resistance Level
- ERAS $1.81
- NUS $8.97
- Average True Range (ATR)
- ERAS 0.12
- NUS 0.37
- MACD
- ERAS -0.03
- NUS -0.11
- Stochastic Oscillator
- ERAS 7.45
- NUS 18.13
About ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About NUS Nu Skin Enterprises Inc.
Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.